Skip to main content
logo
Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025

Verona Pharma Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Verona Pharma stock had an average target of $114.1, with a low estimate of $57 and a high estimate of $170.

Price Target: $114.1 (+6.73%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$57$114.1n/a$170
Change-46.68%+6.73%n/a+59.01%

Analyst Ratings

The average analyst rating for Verona Pharma stock from 11 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingNov 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
427.00M
from 42.28M
Increased by 909.96%
Revenue Next Year
753.54M
from 427.00M
Increased by 76.47%
EPS This Year
0.52
from -2.16
EPS Next Year
2.20
from 0.52
Increased by 325.94%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-40.00M458.00K-42.28M427.00M753.54M
Revenue Growth
---98.86%--909.96%76.47%
EPS
-1.98-0.94-1.04-0.72-2.160.522.20
EPS Growth
------325.94%
Forward PE
-----206.5348.49
No. Analysts
-----1111

Revenue Forecast

Revenue20252026202720282029
High514.5M943.3M
Avg427.0M753.5M
Low361.7M545.6M

Revenue Growth

Revenue Growth20252026202720282029
High
1,116.9%
120.9%
Avg
910.0%
76.5%
Low
755.5%
27.8%

EPS Forecast

EPS20252026202720282029
High1.564.46
Avg0.522.20
Low-0.110.37

EPS Growth

EPS Growth20252026202720282029
High-
762.1%
Avg-
325.9%
Low-
-28.1%